Value-based care toolkits for cell and gene therapies

Published on January 19, 2023

Cell and gene therapies (CGTs) offer tremendous promise to patients in indications with high unmet need. This includes multiple therapeutic areas such as oncology, rare diseases, and neurological disorders. But manufacturers face several challenges related to pricing and access of these products – here’s where a value-based care toolkit can help.

Of the more than 3,000 cell and gene therapies currently in the pipeline, about 25 products are in phase 3, and the highest number of potential developments are seen in oncology. Although many of these therapies have curative intent and target small patient populations, manufacturers face numerous challenges related to pricing and access of these products. Despite promising evidence of clinical benefit and innovation, payers and HTA bodies have many…

Continue reading on website
Other news

Building a Winning F&B and CPG Sales Team in the Post-Pandemic Landscape

January 19, 2023
Massive demand spikes and sudden shifts in consumer behaviors during the pandemic strained and stressed sales organization structures in food and beverage (F&B) and consumer packaged goods (CPG). Now that COVID-19 is behind us, how should sales leaders approach optimizing their sales teams to drive growth? What forces of change did the pandemic unleash and how will they reshape the industry?As the

Dynamic Pricing – Auswirkungen auf Händler und Hersteller

January 19, 2023
Derzeit kündigen viele Händler die Einführung von Dynamic Pricing an, ohne zu wissen, was sich genau dahinter verbirgt. Unsere internationalen Experten beleuchten die Herausforderungen und Fallstricke für den Einzelhandel und Hersteller.Dynamic Pricing für HändlerMithilfe von Dynamic Pricing, also der dynamischen Preisgestaltung, können…